{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Xu L"],"funding":["National Basic Research Program of China","Shanghai Municipal Education Commission-Gaofeng Clinical Medicine"],"pagination":["2589586"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12697273"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["47(1)"],"pubmed_abstract":["This study investigated the clinical outcomes and mortality risks in elderly peritoneal dialysis (PD) patients with diabetes mellitus (DM). A total of 210 incident PD patients aged 70 years or older (mean age 80.7 ± 5.0 years; 60.5% men) who initiated treatment between 2009 and 2020 were analyzed, including 81 (38.6%) with DM. Compared with non-diabetic patients, those with DM were younger (79.6 ± 4.7 vs. 81.4 ± 5.0 years, <i>p</i> = 0.011), and had higher fasting glucose (6.18 [4.53-9.30] vs. 4.88 [4.40-5.63] mmol/L, <i>p</i> < 0.001) and HbA1c (6.10% [5.43-6.78] vs. 5.40% [5.00-5.70], <i>p</i> < 0.001). Annualized mortality was 0.22 deaths per patient-year (95% CI 0.16-0.29) in the DM group and 0.20 (95% CI 0.16-0.25) in the non-DM group. Kaplan-Meier survival analysis revealed no signif"],"journal":["Renal failure"],"pubmed_title":["Impact of diabetes on survival and clinical outcomes in elderly patients receiving peritoneal dialysis."],"pmcid":["PMC12697273"],"funding_grant_id":["20152211","81370864","81670691"],"pubmed_authors":["Xu L","Ni Z","Qian Y","Li Z","Huang J","Fang W","Song Q","Gu L","Yu Z","Yan H","Jiang N","Yuan J"],"additional_accession":[]},"is_claimable":false,"name":"Impact of diabetes on survival and clinical outcomes in elderly patients receiving peritoneal dialysis.","description":"This study investigated the clinical outcomes and mortality risks in elderly peritoneal dialysis (PD) patients with diabetes mellitus (DM). A total of 210 incident PD patients aged 70 years or older (mean age 80.7 ± 5.0 years; 60.5% men) who initiated treatment between 2009 and 2020 were analyzed, including 81 (38.6%) with DM. Compared with non-diabetic patients, those with DM were younger (79.6 ± 4.7 vs. 81.4 ± 5.0 years, <i>p</i> = 0.011), and had higher fasting glucose (6.18 [4.53-9.30] vs. 4.88 [4.40-5.63] mmol/L, <i>p</i> < 0.001) and HbA1c (6.10% [5.43-6.78] vs. 5.40% [5.00-5.70], <i>p</i> < 0.001). Annualized mortality was 0.22 deaths per patient-year (95% CI 0.16-0.29) in the DM group and 0.20 (95% CI 0.16-0.25) in the non-DM group. Kaplan-Meier survival analysis revealed no signif","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-05-26T17:04:12.16Z","creation":"2026-05-24T03:11:42.264Z"},"accession":"S-EPMC12697273","cross_references":{"pubmed":["41371617"],"doi":["10.1080/0886022X.2025.2589586"]}}